Quest Diagnostics ($DGX) Board of Directors authorized an additional $1.0B of common stock repurchases…
Filed with the SEC on · Summarized by InvestorsBot
Quest Diagnostics ($DGX) Board of Directors authorized an additional $1.0B of common stock repurchases under its ongoing program — announced Feb 10, 2026. Boosts capital return capacity; timing/pace not specified. 💵📈 #ShareBuyback #Healthcare
Quest Diagnostics ($DGX) raises quarterly dividend 7.5% to $0.86 from $0.80. Payable Apr 20, 2026 to shareholders of record Apr 6, 2026 — announced Feb 10, 2026. 📅💸 #Dividend #IncomeInvesting